[Role of dopamine in Huntington's disease].

Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci U S A (2004) 3.87

ERK2: a logical AND gate critical for drug-induced plasticity? Curr Opin Pharmacol (2006) 2.50

Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur J Neurosci (2004) 2.42

Parsing molecular and behavioral effects of cocaine in mitogen- and stress-activated protein kinase-1-deficient mice. J Neurosci (2005) 2.01

Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: a new route to cAMP response element-binding protein phosphorylation. J Neurosci (2002) 1.54

Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J Neurosci (2003) 1.53

Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine. Br J Pharmacol (2002) 1.53

A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition. Hum Mol Genet (2006) 1.51

Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments. Curr Opin Neurol (2008) 1.40

Role of the ERK/MSK1 signalling pathway in chromatin remodelling and brain responses to drugs of abuse. J Neurochem (2009) 1.34

Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) controls activation of extracellular signal-regulated kinase (ERK) signaling in the striatum and long-term behavioral responses to cocaine. Biol Psychiatry (2009) 1.21

Cyclic adenosine monophosphate-independent tyrosine phosphorylation of NR2B mediates cocaine-induced extracellular signal-regulated kinase activation. Biol Psychiatry (2010) 1.18

Foreground contextual fear memory consolidation requires two independent phases of hippocampal ERK/CREB activation. Learn Mem (2006) 1.18

Elk-1 a transcription factor with multiple facets in the brain. Front Neurosci (2011) 1.15

Reconsolidation of memory: a decade of debate. Prog Neurobiol (2012) 1.13

Plasticity-associated gene Krox24/Zif268 is required for long-lasting behavioral effects of cocaine. J Neurosci (2006) 1.12

Axon diodes for the reconstruction of oriented neuronal networks in microfluidic chambers. Lab Chip (2011) 1.08

Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death. FASEB J (2007) 1.05

Glutamate induces histone H3 phosphorylation but not acetylation in striatal neurons: role of mitogen- and stress-activated kinase-1. J Neurochem (2007) 1.05

Huntington's disease. Adv Exp Med Biol (2010) 1.03

Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation. Proc Natl Acad Sci U S A (2005) 1.01

A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson's disease. J Pharmacol Exp Ther (2012) 1.01

The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module. J Neurosci (2002) 0.96

A TAT-DEF-Elk-1 peptide regulates the cytonuclear trafficking of Elk-1 and controls cytoskeleton dynamics. J Neurosci (2007) 0.95

Direct and indirect interactions between cannabinoid CB1 receptor and group II metabotropic glutamate receptor signalling in layer V pyramidal neurons from the rat prefrontal cortex. Eur J Neurosci (2003) 0.92

Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter. Hum Mol Genet (2011) 0.90

ADX71743, a potent and selective negative allosteric modulator of metabotropic glutamate receptor 7: in vitro and in vivo characterization. J Pharmacol Exp Ther (2012) 0.90

Extracellular signal-regulated kinases (ERKs) modulate cocaine-induced gene expression in the mouse amygdala. Eur J Neurosci (2005) 0.90

Multiple Aspects of Gene Dysregulation in Huntington's Disease. Front Neurol (2013) 0.89

Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo. Neurobiol Dis (2007) 0.89

Quantitative gene expression profiling of mouse brain regions reveals differential transcripts conserved in human and affected in disease models. Physiol Genomics (2008) 0.89

A deconvolution method to improve automated 3D-analysis of dendritic spines: application to a mouse model of Huntington's disease. Brain Struct Funct (2011) 0.86

Huntington's Disease and Striatal Signaling. Front Neuroanat (2011) 0.86

Dopamine D2 receptor stimulation potentiates PolyQ-Huntingtin-induced mouse striatal neuron dysfunctions via Rho/ROCK-II activation. PLoS One (2009) 0.86

Comparative dynamics of MAPK/ERK signalling components and immediate early genes in the hippocampus and amygdala following contextual fear conditioning and retrieval. Brain Struct Funct (2013) 0.85

Alterations of molecular and behavioral responses to cocaine by selective inhibition of Elk-1 phosphorylation. J Neurosci (2011) 0.85

Insulin-like growth factor-1 and neurotrophin-3 gene therapy prevents motor decline in an X-linked adrenoleukodystrophy mouse model. Ann Neurol (2009) 0.83

Endocytosis controls glutamate-induced nuclear accumulation of ERK. Mol Cell Neurosci (2009) 0.81

A new automated 3D detection of synaptic contacts reveals the formation of cortico-striatal synapses upon cocaine treatment in vivo. Brain Struct Funct (2014) 0.80

Recall and reconsolidation of contextual fear memory: differential control by ERK and Zif268 expression dosage. PLoS One (2013) 0.79

Implication of CCR2 chemokine receptor in cocaine-induced sensitization. J Mol Neurosci (2011) 0.77

A novel series of metabotropic glutamate receptor 5 negative allosteric modulators based on a 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine core. Bioorg Med Chem Lett (2013) 0.75